ASENT 2023 is the premier neuroscience and neurotherapeutics conference where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather with one central focus, improving the process of bringing neurotherapeutics to market. Beginning in January 2024, The American Society for Experimental Neurotherapeutics (ASENT) is excited to announce that Neurotherapeutics will be published in partnership with Elsevier and move

ASENT 2023 is the premier neuroscience and neurotherapeutics conference where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather with one central focus, improving the process of bringing neurotherapeutics to market. Beginning in January 2024, The American Society for Experimental Neurotherapeutics (ASENT) is excited to announce that Neurotherapeutics will be published in partnership with Elsevier and move

ASENT 2023 is the premier neuroscience and neurotherapeutics conference where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather with one central focus, improving the process of bringing neurotherapeutics to market. Beginning in January 2024, The American Society for Experimental Neurotherapeutics (ASENT) is excited to announce that Neurotherapeutics will be published in partnership with Elsevier and move